Pubblicità
Health

Fujifilm Healthcare unveils Synapse Pathology at the European Congress of Pathology: digital diagnosis reimagined

Pubblicità
Published by
Team Italia News
Pubblicità
Condividi

At the 36th European Congress of Pathology (ECP), Fujifilm Healthcare introduced Synapse Pathology, a cutting-edge solution for the digital transformation of anatomical pathology. With integrated artificial intelligence, the platform provides simplified workflows, faster diagnoses, and enhanced collaboration among specialists.

The importance of Synapse Pathology in digital diagnosis

Synapse Pathology is a comprehensive digital solution designed to support Pathology Departments with advanced reporting and integrated analysis features. The platform offers quick access to images and fosters multidisciplinary collaboration, improving efficiency in managing pathology cases.

The introduction of Synapse Pathology Gateway marks a significant advancement in digital transformation, enhancing interoperability between healthcare facilities and reducing diagnostic time.

Artificial intelligence at the service of healthcare

With its integrated AI, Synapse Pathology can process digital images 1.7 hours faster than traditional glass slides, enabling pathologists to consult and diagnose cases remotely. This technology not only accelerates diagnostic time but also improves the efficiency and quality of healthcare services.

Fujifilm Healthcare’s strategic collaborations

At the ECP event, Fujifilm Healthcare highlighted its collaborations with global leaders like Ibex and AWS. These partnerships reinforce the offering of innovative solutions for digital pathology and demonstrate the company’s commitment to improving healthcare workflows through advanced collaboration and diagnostic tools.

Pubblicità
Share
Team Italia News
Published by
Team Italia News

Recent Posts

Libera di sognare: a poetic journey to the true self

The courage to remove the mask "I wore so many masks that I forgot who…

9 September 2024

Angelini Pharma: new data on cenobamate demonstrate prolonged benefits in epilepsy treatment

Introduction to the new clinical data Angelini Pharma recently presented the results of long-term clinical…

9 September 2024

Partnerships between companies and universities: young people at the center of Italy’s industrial recovery

The role of young people in the industry’s growth According to the MECSPE Observatory, over…

9 September 2024

Giorgio Possagno appointed as the new director general of Assocalzaturifici

Milan, September 9, 2024 – Giorgio Possagno has been appointed as the new Director General…

9 September 2024

Jannik Sinner: an example of success and determination for all

An inspiring success Jannik Sinner’s victory at the 2024 US Open, his second Grand Slam…

9 September 2024

Italian household consumption: 30% spent on housing, only 1% on education

Italian household spending: a snapshot of 2023 According to an analysis by the Centro studi…

7 September 2024
Pubblicità